375 related articles for article (PubMed ID: 28592461)
1. RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the
Ohe K; Yoshida M; Nakano-Kobayashi A; Hosokawa M; Sako Y; Sakuma M; Okuno Y; Usui T; Ninomiya K; Nojima T; Kataoka N; Hagiwara M
RNA; 2017 Sep; 23(9):1393-1403. PubMed ID: 28592461
[TBL] [Abstract][Full Text] [Related]
2. Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
Yoshida M; Kataoka N; Miyauchi K; Ohe K; Iida K; Yoshida S; Nojima T; Okuno Y; Onogi H; Usui T; Takeuchi A; Hosoya T; Suzuki T; Hagiwara M
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2764-9. PubMed ID: 25675486
[TBL] [Abstract][Full Text] [Related]
3. Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells.
Bruun GH; Bang JMV; Christensen LL; Brøner S; Petersen USS; Guerra B; Grønning AGB; Doktor TK; Andresen BS
Nucleic Acids Res; 2018 Sep; 46(15):7938-7952. PubMed ID: 29762696
[TBL] [Abstract][Full Text] [Related]
4. Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model.
Donadon I; Pinotti M; Rajkowska K; Pianigiani G; Barbon E; Morini E; Motaln H; Rogelj B; Mingozzi F; Slaugenhaupt SA; Pagani F
Hum Mol Genet; 2018 Jul; 27(14):2466-2476. PubMed ID: 29701768
[TBL] [Abstract][Full Text] [Related]
5. Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.
Morini E; Dietrich P; Salani M; Downs HM; Wojtkiewicz GR; Alli S; Brenner A; Nilbratt M; LeClair JW; Oaklander AL; Slaugenhaupt SA; Dragatsis I
Hum Mol Genet; 2016 Mar; 25(6):1116-28. PubMed ID: 26769677
[TBL] [Abstract][Full Text] [Related]
6. Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia.
Ibrahim EC; Hims MM; Shomron N; Burge CB; Slaugenhaupt SA; Reed R
Hum Mutat; 2007 Jan; 28(1):41-53. PubMed ID: 16964593
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice.
Sinha R; Kim YJ; Nomakuchi T; Sahashi K; Hua Y; Rigo F; Bennett CF; Krainer AR
Nucleic Acids Res; 2018 Jun; 46(10):4833-4844. PubMed ID: 29672717
[TBL] [Abstract][Full Text] [Related]
8. Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.
Liu B; Anderson SL; Qiu J; Rubin BY
FEBS J; 2013 Aug; 280(15):3632-46. PubMed ID: 23711097
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia.
Ajiro M; Awaya T; Kim YJ; Iida K; Denawa M; Tanaka N; Kurosawa R; Matsushima S; Shibata S; Sakamoto T; Studer L; Krainer AR; Hagiwara M
Nat Commun; 2021 Jul; 12(1):4507. PubMed ID: 34301951
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model.
Bochner R; Ziv Y; Zeevi D; Donyo M; Abraham L; Ashery-Padan R; Ast G
Hum Mol Genet; 2013 Jul; 22(14):2785-94. PubMed ID: 23515154
[TBL] [Abstract][Full Text] [Related]
11. Familial dysautonomia.
Slaugenhaupt SA; Gusella JF
Curr Opin Genet Dev; 2002 Jun; 12(3):307-11. PubMed ID: 12076674
[TBL] [Abstract][Full Text] [Related]
12. A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect.
Hims MM; Shetty RS; Pickel J; Mull J; Leyne M; Liu L; Gusella JF; Slaugenhaupt SA
Genomics; 2007 Sep; 90(3):389-96. PubMed ID: 17644305
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.
Cuajungco MP; Leyne M; Mull J; Gill SP; Lu W; Zagzag D; Axelrod FB; Maayan C; Gusella JF; Slaugenhaupt SA
Am J Hum Genet; 2003 Mar; 72(3):749-58. PubMed ID: 12577200
[TBL] [Abstract][Full Text] [Related]
14. Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.
Gold-von Simson G; Goldberg JD; Rolnitzky LM; Mull J; Leyne M; Voustianiouk A; Slaugenhaupt SA; Axelrod FB
Pediatr Res; 2009 Mar; 65(3):341-6. PubMed ID: 19033881
[TBL] [Abstract][Full Text] [Related]
15. SAM68 interaction with U1A modulates U1 snRNP recruitment and regulates mTor pre-mRNA splicing.
Subramania S; Gagné LM; Campagne S; Fort V; O'Sullivan J; Mocaer K; Feldmüller M; Masson JY; Allain FHT; Hussein SM; Huot MÉ
Nucleic Acids Res; 2019 May; 47(8):4181-4197. PubMed ID: 30767021
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia.
Hervé M; Ibrahim EC
Dis Model Mech; 2016 Aug; 9(8):899-909. PubMed ID: 27483351
[TBL] [Abstract][Full Text] [Related]
17. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
[TBL] [Abstract][Full Text] [Related]
18. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.
Anderson SL; Qiu J; Rubin BY
Biochem Biophys Res Commun; 2003 Oct; 310(2):627-33. PubMed ID: 14521957
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of exon-bridging activity with purified U2AF and U1 snRNP components.
Cunningham TP; Hagan JP; Grabowski PJ
Nucleic Acids Symp Ser; 1995; (33):218-9. PubMed ID: 8643375
[TBL] [Abstract][Full Text] [Related]
20. ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.
Morini E; Gao D; Montgomery CM; Salani M; Mazzasette C; Krussig TA; Swain B; Dietrich P; Narasimhan J; Gabbeta V; Dakka A; Hedrick J; Zhao X; Weetall M; Naryshkin NA; Wojtkiewicz GG; Ko CP; Talkowski ME; Dragatsis I; Slaugenhaupt SA
Am J Hum Genet; 2019 Apr; 104(4):638-650. PubMed ID: 30905397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]